AU2003209049A1 - Methods of treating and diagnosing arthritis - Google Patents

Methods of treating and diagnosing arthritis

Info

Publication number
AU2003209049A1
AU2003209049A1 AU2003209049A AU2003209049A AU2003209049A1 AU 2003209049 A1 AU2003209049 A1 AU 2003209049A1 AU 2003209049 A AU2003209049 A AU 2003209049A AU 2003209049 A AU2003209049 A AU 2003209049A AU 2003209049 A1 AU2003209049 A1 AU 2003209049A1
Authority
AU
Australia
Prior art keywords
treating
methods
diagnosing arthritis
diagnosing
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209049A
Other versions
AU2003209049A8 (en
Inventor
Christophe O. Benoist
Diane J. Mathis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joslin Diabetes Center Inc
Original Assignee
Joslin Diabetes Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joslin Diabetes Center Inc filed Critical Joslin Diabetes Center Inc
Publication of AU2003209049A8 publication Critical patent/AU2003209049A8/en
Publication of AU2003209049A1 publication Critical patent/AU2003209049A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
AU2003209049A 2002-02-11 2003-02-06 Methods of treating and diagnosing arthritis Abandoned AU2003209049A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35604102P 2002-02-11 2002-02-11
US60/356,041 2002-02-11
US35777502P 2002-02-19 2002-02-19
US60/357,775 2002-02-19
PCT/US2003/003708 WO2003068150A2 (en) 2002-02-11 2003-02-06 Methods of treating and diagnosing arthritis

Publications (2)

Publication Number Publication Date
AU2003209049A8 AU2003209049A8 (en) 2003-09-04
AU2003209049A1 true AU2003209049A1 (en) 2003-09-04

Family

ID=27737514

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003209049A Abandoned AU2003209049A1 (en) 2002-02-11 2003-02-06 Methods of treating and diagnosing arthritis

Country Status (2)

Country Link
AU (1) AU2003209049A1 (en)
WO (1) WO2003068150A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
US8580735B2 (en) * 2007-02-05 2013-11-12 Apellis Pharmaceuticals, Inc. Local complement inhibition for treatment of complement-mediated disorders
EP2968444A1 (en) 2013-03-14 2016-01-20 Baxalta Incorporated Factor h for treatment of rheumatoid arthritis
JP7156827B2 (en) * 2018-06-08 2022-10-19 デンカ株式会社 Reagent for measuring complement titer and method for stabilizing measured value of complement titer using the same
EP3771468A1 (en) * 2019-07-31 2021-02-03 Universitätsklinikum Hamburg-Eppendorf C3/c5 convertase assays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033603A1 (en) * 1996-03-13 1997-09-18 Trustees Of The University Of Pennsylvania Novel peptides which inhibit complement activation
US6956107B2 (en) * 1998-02-20 2005-10-18 Tanox, Inc. Inhibitors of complement activation
US6414218B1 (en) * 2000-01-18 2002-07-02 The General Hospital Corporation Mouse model for rheumatoid arthritis

Also Published As

Publication number Publication date
AU2003209049A8 (en) 2003-09-04
WO2003068150A2 (en) 2003-08-21
WO2003068150A3 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003275311A1 (en) Solid micro-perforators and methods of use
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
AU2003216363A1 (en) Massager and method of using same
AU2003259925A1 (en) Well treatment apparatus and method
EP1398930A4 (en) Radio-frequency-signal-receiver and method of manufacturing the same
AU2003232485A1 (en) Neopeptides and methods useful for detection and treatment of cancer
AU2003282558A1 (en) Nanopellets and method of making nanopellets
AU2003277259A1 (en) Immunoassay and method of use
AU2003209851A1 (en) Method of treatment and/or prophylaxis
AU2003254803A1 (en) Sliding part and method of manufacturing the sliding part
AU2003254942A1 (en) Treating apparatus and method of treating
AU2002350319A1 (en) Method and system for the treatment of wastewater
AU2003213365A1 (en) Prism and method of producing the same
AU2003292231A1 (en) Methods for diagnosing and treating schizophrenia
AU2003288387A1 (en) Droplet - deposition related methods and apparatus
EP1491091A4 (en) Insect-proofing means and method of insect-proofing
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003209049A1 (en) Methods of treating and diagnosing arthritis
AU2003225471A1 (en) System and method of authentifying
AU2003276398A1 (en) Shearwall structure and method of making the same
AU2003273362A1 (en) Scrubber and method of using scrubber
AU2003280017A1 (en) Methods of treating or preventing ibd with il-18
AU2003274437A1 (en) Method of ameliorating vision-inhibiting effects of cataracts and the like
AU2003300781A1 (en) Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof
AU2003270622A1 (en) Methods of diagnosing and treating hyperproliferative disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase